NASDAQ:ALQA

Alliqua Biomedical (ALQA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$2.20
$3.23
52-Week Range
N/A
Volume
371,516 shs
Average Volume
114,400 shs
Market Capitalization
$13.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ALQA stock logo

About Alliqua Biomedical Stock (NASDAQ:ALQA)

Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.

ALQA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive ALQA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliqua Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/09/2016
Today
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:ALQA
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
$-8,420,000.00
Net Margins
-230.50%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.22 million
Book Value
$1.65 per share

Miscellaneous

Free Float
N/A
Market Cap
$13.46 million
Optionable
Not Optionable
Beta
2.03
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. David Ian Johnson (Age 61)
    Pres, CEO, Principal Financial Officer & Director
  • Dr. Phillip D. Forman M.D. (Age 60)
    DPM, Exec. VP of Clinical Affairs
  • Mr. Joseph M. Warusz (Age 63)
    CFO, Treasurer & Sec.

ALQA Stock Analysis - Frequently Asked Questions

How were Alliqua Biomedical's earnings last quarter?

Alliqua Biomedical Inc (NASDAQ:ALQA) announced its quarterly earnings data on Tuesday, August, 9th. The company reported $0.50 EPS for the quarter, topping analysts' consensus estimates of ($2.70) by $3.20. The firm earned $5.50 million during the quarter, compared to analyst estimates of $5.38 million. Alliqua Biomedical had a negative trailing twelve-month return on equity of 71.73% and a negative net margin of 230.50%.

When did Alliqua Biomedical's stock split?

Alliqua Biomedical's stock reverse split on Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Alliqua Biomedical own?
This page (NASDAQ:ALQA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners